Wall Street Zen lowered shares of KalVista Pharmaceuticals (NASDAQ:KALV – Free Report) from a buy rating to a hold rating in a research note published on Sunday. Several other research analysts have also recently weighed in on KALV. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of KalVista Pharmaceuticals in a research report on […]

Wall Street Zen upgraded shares of Tarsus Pharmaceuticals (NASDAQ:TARS – Free Report) from a hold rating to a buy rating in a report published on Saturday. A number of other brokerages also recently commented on TARS. Guggenheim lifted their price objective on Tarsus Pharmaceuticals from $87.00 to $90.00 and gave the stock a “buy” rating […]

Wall Street Zen upgraded shares of KalVista Pharmaceuticals (NASDAQ:KALV – Free Report) from a hold rating to a buy rating in a research note published on Saturday morning. Other equities research analysts have also recently issued research reports about the company. TD Cowen reiterated a “buy” rating on shares of KalVista Pharmaceuticals in a research […]

Tonix Pharmaceuticals (NASDAQ:TNXP – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Saturday. Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Tonix Pharmaceuticals in a research note on Wednesday, January […]

Milestone Pharmaceuticals (NASDAQ:MIST – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “sell” rating to a “hold” rating in a research note issued to investors on Saturday. Several other brokerages also recently issued reports on MIST. Weiss Ratings reiterated a “sell (d-)” rating on shares of Milestone Pharmaceuticals in […]